What to watch: AstraZeneca launches diabetes drug

AstraZeneca Pharma India on Wednesday launched an anti-diabetic tablet ‘Xigduo XR’ used for the treatment of type 2 diabetes in adults. The drug is a product of AstraZeneca group and is approved in 61 countries, including the US, the EU and Japan, AstraZeneca said. It is a combination of metformin and dapagliflozin, an inhibitor of sodium-glucose cotransporter 2, it added. Xigduo XR is available in multiple dosage strengths. Investors will closely watch the development.